Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma
NCT01987934 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2013-11-20
Summary
Oral cancer represents the sixth most common cancer worldwide whilst in Pakistan it ranks the second most common cancer in either gender. Histologically, over 90% of oral cancer lesions are squamous cell carcinomas which are diagnosed on the basis of histopathological analysis. However, proliferation kinetics and nucleolar status are not clearly delineated by routine H\&E examination; thus making use of various proliferation markers imperative for the purpose.
Nuclear organizer regions (AgNORs) are associated with proliferative activity and represents as a diagnostic aid in oral malignancies. Similarly, methyl green pyronin (MGP) stain has also been valuable as a complement in routine histopathological studies of several neoplastic entities.
Morphometric techniques offer an opportunity to quantify nuclear changes associated with malignancy and may provide an objective basis for grading the tumors. The present study is planned to analyze the morphometric parameters of the MGP stain in oral squamous cell carcinoma, and in their various histological grades, and to assess if the MGP staining parameters could give information on the aggressiveness of the malignant lesions of oral cavity.
Sections from thirty cases of squamous cell carcinoma along with thirty cases of normal oral mucosa will be evaluated for methyl green pyronin (MGP) and AgNOR staining. Morphometric analysis of various MGP staining and AgNOR parameters would be performed using micrometer. Statistical analysis of the results will be carried out using SPSS. Quantitative variables will be expressed as mean ± Standard Deviation. Frequencies and percentages will be given for qualitative variables.
It is hypothesized that oral squamous cell carcinoma will exhibit significantly higher MGP staining and AgNOR staining parameters than normal mucosa of the oral cavity.
Conditions
- Oral Squamous Cell Carcinoma
- Oral Epithelial Dysplasia
Sponsors & Collaborators
-
Postgraduate Medical Institute, Lahore
collaborator OTHER -
Academy of Interdisciplinary Dental Education and Research
lead OTHER
Principal Investigators
-
Muhammad Eyyaz Khaleel, M.Phil · Postgraduate Medical Institute, Lahore
-
Ali Raza, B.D.S · Postgraduate Medical Institute, Lahore
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2013-11-30
- Completion
- 2013-12-31
Countries
- Pakistan
Study Locations
More Related Trials
-
The Role of microRNA-29b in the Oral Squamous Cell Carcinoma
NCT02009852 ·Status: UNKNOWN
-
8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions
NCT03830710 ·Status: COMPLETED
-
Oral Health Related Quality of Life in Head and Neck Cancer Survivors Within the First Year Following Treatment
NCT06730139 ·Status: COMPLETED
-
Validation of Salivary Proteomic Biomarkers for Early Detection of Oral Cancer in Egyptian Population
NCT06471270 ·Status: COMPLETED ·Phase: NA
-
The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw
NCT03418454 ·Status: UNKNOWN
-
Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
NCT06031337 ·Status: COMPLETED
-
Dipeptidyl Peptidase-4 Link With Oral Cancer and Premalignant Lesions
NCT06087042 ·Status: COMPLETED
-
Evaluation of the Levels of Salivary Paxillin Oral Premalignant and Malignant Lesions
NCT06154551 ·Status: COMPLETED
-
Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity
NCT01636544 ·Status: COMPLETED ·Phase: NA
-
Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma
NCT00201279 ·Status: COMPLETED ·Phase: PHASE3
-
the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients
NCT05400057 ·Status: COMPLETED
-
Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
NCT00154973 ·Status: UNKNOWN
-
Oral Microbioma and Oral Malignant Disease
NCT05766150 ·Status: UNKNOWN
-
Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors
NCT07090070 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions
NCT04732741 ·Status: UNKNOWN
-
Oral Health-Related Quality of Life Using EORTC QLQ-H&N35 in Head and Neck Cancer Survivors Within the First Year Following Treatment: a Cross-Sectional Study in Egypt
NCT06901401 ·Status: ACTIVE_NOT_RECRUITING
-
Mucin Glycosylating Enzymes in Head and Neck Cancers
NCT01976377 ·Status: UNKNOWN
-
Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line
NCT03619304 ·Status: UNKNOWN ·Phase: NA
-
Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass Spectroscopy
NCT05150509 ·Status: UNKNOWN
-
The Oral Microbiome in OSCC
NCT04925700 ·Status: COMPLETED ·Phase: NA
-
Early Diagnosis of Oral Cancer by Detecting p16 Hydroxymethylation
NCT02967120 ·Status: UNKNOWN
-
Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
NCT03975322 ·Status: RECRUITING
-
The Senstivity and Specificity of Using Salivary miRNAs in Detection of Malignant Transformation of Oral Lesions.
NCT04913545 ·Status: COMPLETED
-
Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
NCT00507182 ·Status: COMPLETED ·Phase: NA
-
Exfoliated Cytology in Detection of Oral Premalignant and Malignant Lesions
NCT04955197 ·Status: UNKNOWN